Quest Diagnostics (NYSE: DGX), announced on Wednesday that its board of directors declared a quarterly cash dividend of USD0.53 per share.
The dividend is payable on 29 January 2020 to shareholders of record of Quest Diagnostics common stock on 14 January 2020.
Quest Diagnostics is a provider of diagnostic information services. Derived from the world's largest database of clinical lab results, the company's diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviours and improve health care management.
ValiRx subsidiary Inaphaea extends drug repurposing deal with Dominion Biotech
Lilly declares Q2 2025 dividend
Bruker acquires majority stake in RECIPE to expand clinical mass spectrometry diagnostics
Emmaus Life Sciences reports drop in revenues, increased loss in 2024
L'Oréal and WHO Foundation partner to expand global skin health access
Valneva to supply IXCHIQ vaccine for chikungunya outbreak in La Réunion
ANI Pharmaceuticals announces buyout of royalty obligation for ILUVIEN and YUTIQ
Sirum collaborates with Governor Wes Moore to expand medication access across Maryland